Craft

Emyria

Stock Price

$0

2024-10-04

Market Capitalization

$13.7 M

2024-10-04

Revenue

$1.3 M

FY, 2025

Emyria Summary

Company Summary

Overview
Emyria is a company that provides healthcare services. It offers clinical research, data science, mental health, cannabinoid medicine, and other services.
Type
Public
Status
Active
Founded
2018
Website
https://www.emeraldclinics.com.au
Cybersecurity rating
Sectors

Table of Contents

Emyria Financials

Summary Financials

Revenue (H1, 2026)
$1.6M
Gross profit (H1, 2026)
$409.0K
Net income (H1, 2026)
($2.4M)
Cash (H1, 2026)
$10.5M
EBIT (H1, 2026)
($2.3M)

Footer menu